InvestorsHub Logo
Followers 532
Posts 31795
Boards Moderated 2
Alias Born 09/23/2010

Re: None

Tuesday, 04/21/2020 10:16:27 AM

Tuesday, April 21, 2020 10:16:27 AM

Post# of 440
NSTM news today. https://www.otcmarkets.com/stock/NSTM/news/story?e&id=1580585

NovelStem Announces New Research Collaborations for Stem-Cell Technology Platform in Cancer Immunotherapy and COVID-19 Resistance; Reports Progress Identifying Genetic Resistance to Additional Anti-Cancer Treatments
Screening of resistance diagnostics completed for twelve standard-of-care cancer treatments representing a significant portion of cancer treatment protocols.
COVID-19 research collaboration initiated to identify genes regulating the virus in order to generate virus resistance and find therapies for the devastating disease.
Selected by leading NASDAQ biopharma to conduct research for development of a potential new cancer immunotherapy biopharmaceutical and the potential discovery of new drug targets.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NSTM News